$59.960
+0.108 (+0.18%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
CGON Prediction & Forecast by Similar Chart Analysis
Alphio's CGON stock price prediction model matches the current CG Oncology Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $59.08 (-1.47%). The 1-week path is $58.54 (-2.36%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy CG Oncology Inc Stock?
CG Oncology Inc is not a good buy right now due to significant financial losses and negative technical indicators. The current price is $59.85, with an RSI of 18.48 indicating oversold conditions. The company reported a net income loss of $79,056,000 in Q2 2026, which raises concerns about its profitability and sustainability. The main risk is the ongoing negative earnings trend, with EPS reported at -$0.90, which reflects the company's struggle to achieve profitability amidst rising R&D expenses.
CGON stock price ended at $59.96 on Monday, after rising +0.18%
CG Oncology Inc (CGON) last closed at $59.96, gaining +0.18%. These facts feed the 1-day and 1-week CGON price prediction above.
Forecast Drivers
CG Oncology Inc (CGON) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches CGON, ranked by similarity.
Seasonality analysis for CGON
Historically the probability of a positive October return for CGON is 66.67%. September offers the highest probability of a positive month at 79.03%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.